Dirscherl, Konstantin http://orcid.org/0000-0002-5481-3547
Schläpfer, Martin
Roth Z’graggen, Birgit
Wenger, Roland H
Booy, Christa
Flury-Frei, Renata
Fatzer, Rita
Aloman, Costica
Bartosch, Birke
Parent, Romain
Kurtcuoglu, Vartan http://orcid.org/0000-0003-2665-0995
de Zélicourt, Diane
Spahn, Donat R.
Beck Schimmer, Beatrice
Schadde, Erik
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (310030_179247)
Jubilaeumsstiftung der Schweizerischen Mobiliar Genossenschaft, Bern, Switzerland
Article History
Received: 31 July 2019
Accepted: 5 February 2020
First Online: 9 March 2020
Competing interests
: Conflict of interests not relevant to the manuscript: BBS received a grant from Baxter AG, not related to this work. BBS was a participant of an Advisory Board Meeting of Baxter AG, not related to this topic. BBS chaired a session (Satellite Symposium on ‘General Anaesthesia and its effect on organ function – What do we know?) at Euroanaesthesia 2013, organized by Baxter AG. BBS is associate editor of ‘Anesthesiology’. BBS received a speaker’s fee from Abbvie, Switzerland (Pro/cons of volatile anaesthetics) for a Grand Round talk in a Swiss Hospital in 2017. BBS has a patent 04/10/14 – 20140100278: Injectable formulation for treatment and protection of patients having an inflammatory reaction or an ischemia-reperfusion event; M. Urner, L.K. Limbach, I.K. Herrmann, W.J. Stark, B. Beck Schimmer, applied as PCT (internationally), July 2009.